Teija Parkkari

831 total citations
32 papers, 666 citations indexed

About

Teija Parkkari is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Teija Parkkari has authored 32 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 17 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Teija Parkkari's work include Cannabis and Cannabinoid Research (24 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Pancreatic function and diabetes (6 papers). Teija Parkkari is often cited by papers focused on Cannabis and Cannabinoid Research (24 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Pancreatic function and diabetes (6 papers). Teija Parkkari collaborates with scholars based in Finland, United States and Poland. Teija Parkkari's co-authors include Tapio Nevalainen, Juha R. Savinainen, Jarmo T. Laitinen, Tuomo Laitinen, Dina Navia‐Paldanius, Antti Poso, Jayendra Z. Patel, Fredrik Elinder, Sara I. Börjesson and Sven Hammarström and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Teija Parkkari

32 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teija Parkkari Finland	17	351	293	203	93	81	32	666
Marjolein Soethoudt Netherlands	12	302 0.9×	218 0.7×	120 0.6×	105 1.1×	59 0.7×	15	573
Diego Caprioglio Italy	18	267 0.8×	379 1.3×	86 0.4×	227 2.4×	31 0.4×	54	824
Craig R. Schneider United States	16	207 0.6×	192 0.7×	173 0.9×	181 1.9×	37 0.5×	18	810
Wilhelmina I. Davis United States	11	358 1.0×	271 0.9×	58 0.3×	47 0.5×	31 0.4×	12	843
Kristi L. Whiteaker United States	15	249 0.7×	117 0.4×	142 0.7×	133 1.4×	26 0.3×	21	584
Sonja Hinz Germany	22	737 2.1×	203 0.7×	327 1.6×	340 3.7×	37 0.5×	42	1.4k
Wei Yao China	15	292 0.8×	126 0.4×	59 0.3×	75 0.8×	26 0.3×	44	566
Robert J. Chorvat United States	15	364 1.0×	405 1.4×	272 1.3×	279 3.0×	177 2.2×	38	1.1k
Brian Scott United States	15	337 1.0×	244 0.8×	160 0.8×	401 4.3×	66 0.8×	24	1.0k
P.N. Patil United States	15	412 1.2×	94 0.3×	263 1.3×	77 0.8×	36 0.4×	55	784

Countries citing papers authored by Teija Parkkari

Since Specialization

Citations

This map shows the geographic impact of Teija Parkkari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teija Parkkari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teija Parkkari more than expected).

Fields of papers citing papers by Teija Parkkari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teija Parkkari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teija Parkkari. The network helps show where Teija Parkkari may publish in the future.

Co-authorship network of co-authors of Teija Parkkari

This figure shows the co-authorship network connecting the top 25 collaborators of Teija Parkkari. A scholar is included among the top collaborators of Teija Parkkari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teija Parkkari. Teija Parkkari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heikkinen, Taneli, Timo Bragge, Teija Parkkari, et al.. (2021). Global Rhes knockout in the Q175 Huntington’s disease mouse model. PLoS ONE. 16(10). e0258486–e0258486. 5 indexed citations

Huhtala, Tuulia, Pekka Poutiainen, Jussi Rytkönen, et al.. (2019). Improved synthesis of [18F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors. EJNMMI Radiopharmacy and Chemistry. 4(1). 20–20. 9 indexed citations

Parkkari, Teija, Taneli Heikkinen, Jukka Puoliväli, et al.. (2018). Impaired Performance of the Q175 Mouse Model of Huntington’s Disease in the Touch Screen Paired Associates Learning Task. Frontiers in Behavioral Neuroscience. 12. 226–226. 7 indexed citations

Hytti, Maria, Sofija Andjelić, Niina Piippo, et al.. (2017). CB2 receptor activation causes an ERK1/2-dependent inflammatory response in human RPE cells. Scientific Reports. 7(1). 16169–16169. 14 indexed citations

Aaltonen, Niina, Ewa Kędzierska, Jolanta Orzelska‐Górka, et al.. (2016). In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048). Journal of Pharmacology and Experimental Therapeutics. 359(1). 62–72. 17 indexed citations

Patel, Jayendra Z., Tuomo Laitinen, Dina Navia‐Paldanius, et al.. (2015). Loratadine analogues as MAGL inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(7). 1436–1442. 23 indexed citations

Kaczor, Agnieszka A., Katarzyna M. Targowska‐Duda, Jayendra Z. Patel, et al.. (2015). Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors. Journal of Molecular Modeling. 21(10). 250–250. 27 indexed citations

Patel, Jayendra Z., Tuomo Laitinen, Agnieszka A. Kaczor, et al.. (2015). Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 Inhibitors. Bioorganic & Medicinal Chemistry. 23(19). 6335–6345. 10 indexed citations

Parkkari, Teija, Dina Navia‐Paldanius, Tuomo Laitinen, et al.. (2015). Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists. European Journal of Medicinal Chemistry. 107. 119–132. 20 indexed citations

10.

Patel, Jayendra Z., Tapio Nevalainen, Juha R. Savinainen, et al.. (2014). Optimization of 1,2,5‐Thiadiazole Carbamates as Potent and Selective ABHD6 Inhibitors. ChemMedChem. 10(2). 253–265. 28 indexed citations

11.

Parkkari, Teija, Juha R. Savinainen, Anna Maria Malfitano, et al.. (2014). 1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor. European Journal of Medicinal Chemistry. 74. 524–532. 15 indexed citations

12.

Sarparanta, Mirkka, Anu J. Airaksinen, Maria Hytti, et al.. (2014). Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists. European Journal of Pharmaceutical Sciences. 67. 85–96. 30 indexed citations

13.

Parkkari, Teija, Raisa Haavikko, Tuomo Laitinen, et al.. (2014). Discovery of Triterpenoids as Reversible Inhibitors of α/β-hydrolase Domain Containing 12 (ABHD12). PLoS ONE. 9(5). e98286–e98286. 25 indexed citations

14.

Savinainen, Juha R., Emilia Kansanen, Tatu Pantsar, et al.. (2014). Robust Hydrolysis of Prostaglandin Glycerol Esters by Human Monoacylglycerol Lipase (MAGL). Molecular Pharmacology. 86(5). 522–535. 35 indexed citations

15.

Kuusisto, Anne, Jayendra Z. Patel, Tuomo Laitinen, et al.. (2014). Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Bioorganic & Medicinal Chemistry. 22(23). 6694–6705. 21 indexed citations

16.

Savinainen, Juha R., Jayendra Z. Patel, Teija Parkkari, et al.. (2014). Biochemical and Pharmacological Characterization of the Human Lymphocyte Antigen B-Associated Transcript 5 (BAT5/ABHD16A). PLoS ONE. 9(10). e109869–e109869. 39 indexed citations

17.

Laitinen, Tuomo, Dina Navia‐Paldanius, Teija Parkkari, et al.. (2013). Mutation of Cys242 of Human Monoacylglycerol Lipase Disrupts Balanced Hydrolysis of 1- and 2-Monoacylglycerols and Selectively Impairs Inhibitor Potency. Molecular Pharmacology. 85(3). 510–519. 16 indexed citations

18.

Börjesson, Sara I., Teija Parkkari, Sven Hammarström, & Fredrik Elinder. (2010). Electrostatic Tuning of Cellular Excitability. Biophysical Journal. 98(3). 396–403. 53 indexed citations

19.

Parkkari, Teija, Outi M. H. Salo‐Ahen, Kristiina M. Huttunen, et al.. (2006). Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE). Bioorganic & Medicinal Chemistry. 14(8). 2850–2858. 7 indexed citations

20.

Parkkari, Teija, Juha R. Savinainen, Susanna M. Saario, et al.. (2006). Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide. Bioorganic & Medicinal Chemistry. 14(15). 5252–5258. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact